Viracta Therapeutics Inc.

0.02
-0.00 (-6.54%)
At close: Apr 04, 2025, 3:28 PM

Viracta Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for VIRX stock have an median target of 3, with a low estimate of 2 and a high estimate of 4. The median target predicts an increase of 14900.00% from the current stock price of 0.02.

Target Low Average Median High
Price $2 $3 $3 $4
Change 9900.00% 14900.00% 14900.00% 19900.00%

Latest Analyst Insight Report

RBC Capital maintains an Outperform rating on Vira... Unlock content with Pro Subscription

Updated Nov 14, 2024

Rating Apr 24May 24Aug 24Nov 24
Strong Buy 0000
Buy 2111
Hold 0010
Sell 0000
Strong Sell 0000
Total 2 1 2 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
2.33M
from 0
Increased by -%
EPS This Year
-0.85
from -1.32
Increased by 35.6%
EPS Next Year
-0.56
from -0.85
Increased by 34.1%